IN.PACT™ Admiral™ DCB
The IN.PACT™ Admiral™ drug-coated balloon (DCB) is a clinically proven, primary endovascular therapy that treats femoropopliteal disease, reduces reinterventions, and preserves future treatment options.1 The IN.PACT Admiral DCB is indicated for de novo, restenotic, or in-stent restenotic lesions up to 360 mm with reference vessel diameters of 4 to 7 mm in the superficial femoral or popliteal arteries.
Product Details
Coronary Drug-Coated Balloon
Prevail™ DCB
Understand why the Medtronic paclitaxel-coated PTCA balloon is an effective treatment option for in-stent restenosis, de novo lesions, and small vessels. 3
Product DetailsReferences
1
Laird J. IN.PACT SFA 5-year Results. Presented at VIVA 2018; Las Vegas, NV.
2
Results from the IN.PACT AV Access Clinical Trial found in the IN.PACT AV drug-coated balloon (DCB) Instructions For Use (IFU).
3
Prevail Instructions for Use